Overview
Established in 2005, Mitsubishi Chemical Group Corporation (MCG; formerly Mitsubishi Chemical Holdings Corporation) is one of the world's largest chemical producers, supplying a wide range of industries from automotive and electronics to medical and sport. Its businesses are Mitsubishi Chemical, which makes chemicals, plastics, and textiles; Mitsubishi Tanabe Pharma, which makes pharmaceutical products for central nervous system, oncology, and kidney;
...
Read More Life Sciences Institute, which offers health and medical ICT solutions, next-generation healthcare, and drug discovery; and Nippon Sanso Holdings, which produces industrial gases. Most of its revenue was generated from its home country, Japan.
Read Less
Read More Life Sciences Institute, which offers health and medical ICT solutions, next-generation healthcare, and drug discovery; and Nippon Sanso Holdings, which produces industrial gases. Most of its revenue was generated from its home country, Japan.
Read Less
MANABU CHIKUMOTO
See more contacts
Management of Companies and Enterprises
,
Management, Scientific, and Technical Consulting Services
,
Holding companies, nec
,
Management consulting services
?
?
?
Actual
?
Actual
$29.42 billion
Actual
-5.34%
23.98%
$6.10 million
MAR
?
?
Tokyo:4188
Contacts
Get in Touch with 17 Principals*
-
MANABU CHIKUMOTOPresident
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of March 31, 2025 (12 month period) in USD
Annual Revenue 2024
$29.42 billion
USD
Actual
1 USD = 149.1202 JPY
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $3,119 | $2,382 | $2,326 |
| Net Investing Cash | -$1,650 | -$1,661 | -$864 |
| Net Financing Cash | -$1,621 | -$408 | -$2,255 |
| Net Change in Cash | -$152 | $314 | -$793 |
| Cash at Beginning of Period | $1,993 | $1,648 | $2,344 |
| Cash at End of Period | $1,978 | $1,993 | $1,648 |
| Capital Expenditure | -$1,841 | -$1,884 | -$1,728 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $1,978 | $1,993 | $1,648 |
| Accounts Receivable | $5,716 | $5,424 | $5,539 |
| Inventories | $5,360 | $5,351 | $4,998 |
| Other Current Assets | $1,644 | $1,648 | $1,134 |
| Asset Summary | |||
| Total Current Assets | $14,697 | $14,415 | $13,319 |
| Tangible Fixed Assets | $13,703 | $12,794 | $12,739 |
| Intangible Assets | $3,226 | $3,079 | $3,010 |
| Total Assets | $6,104,513 | $5,774,348 | $5,573,871 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $3,363 | $3,194 | $3,265 |
| Short-Term Debt | $4,059 | $4,033 | $2,758 |
| Other Current Liabilities | $4,145 | $3,930 | $3,495 |
| Liability Summary | |||
| Total Current Liabilities | $11,567 | $11,158 | $9,518 |
| Long-Term Debt | $10,701 | $11,013 | $11,727 |
| Other Long-Term Liabilities | $296 | $268 | $987 |
| Total Liabilities | $25,677 | $25,388 | $25,010 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $335 | $335 | $335 |
| Retained Earnings | $9,088 | $8,520 | $8,139 |
| Equity Summary | |||
| Total Equity | $11,826 | $10,493 | $9,778 |
| Shares Outstanding | 1,422,582,999 | 1,422,098,107 | 1,421,088,107 |